ALMERICO, Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 10.799
EU - Europa 5.903
AS - Asia 1.396
AF - Africa 22
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 18.163
Nazione #
US - Stati Uniti d'America 10.734
IT - Italia 1.777
CN - Cina 1.128
FI - Finlandia 984
UA - Ucraina 889
DE - Germania 615
IE - Irlanda 424
SE - Svezia 363
GB - Regno Unito 274
RU - Federazione Russa 170
FR - Francia 92
BE - Belgio 86
RO - Romania 72
IN - India 69
KR - Corea 51
CA - Canada 48
CZ - Repubblica Ceca 36
IR - Iran 24
TR - Turchia 21
NL - Olanda 20
CH - Svizzera 19
HK - Hong Kong 18
PL - Polonia 18
ES - Italia 16
MX - Messico 16
UZ - Uzbekistan 16
AT - Austria 15
EU - Europa 13
BR - Brasile 12
GR - Grecia 12
JP - Giappone 12
LB - Libano 10
VN - Vietnam 9
TW - Taiwan 8
AU - Australia 7
BG - Bulgaria 7
EG - Egitto 7
HR - Croazia 5
AR - Argentina 4
JO - Giordania 4
MA - Marocco 4
PK - Pakistan 4
SG - Singapore 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
IL - Israele 3
AF - Afghanistan, Repubblica islamica di 2
GH - Ghana 2
HU - Ungheria 2
NG - Nigeria 2
NP - Nepal 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
GL - Groenlandia 1
ID - Indonesia 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
Totale 18.163
Città #
Fairfield 1.330
Ann Arbor 958
Ashburn 956
Chandler 875
Woodbridge 842
Wilmington 676
Houston 648
Seattle 524
Jacksonville 471
Palermo 455
Cambridge 448
Dublin 422
Medford 305
Nanjing 284
Princeton 203
Tulsa 177
Des Moines 162
Dearborn 148
Altamura 104
New York 102
Boardman 98
Jinan 88
Lawrence 87
San Diego 83
Shenyang 83
Beijing 82
Nanchang 79
Hebei 78
Brussels 77
Milan 73
Ludwigshafen am Rhein 66
Changsha 64
Tianjin 62
Jiaxing 48
Seongnam 48
Zhengzhou 45
Redwood City 36
Aversa 34
Brno 34
Munich 34
Rome 33
Saint Petersburg 33
Taizhou 29
Auburn Hills 28
Chicago 28
Ningbo 28
San Mateo 28
Ottawa 27
Kilburn 26
Napoli 25
Washington 25
London 24
Taiyuan 21
Bremen 20
Kumar 20
Hangzhou 19
Haikou 18
Verona 18
Los Angeles 16
Guangzhou 15
Helsinki 15
Izmir 15
Cefalù 14
San Paolo di Civitate 14
Timisoara 14
West Jordan 14
Düsseldorf 12
Kunming 12
Andover 11
Fuzhou 11
Tehran 11
Toronto 11
Alcamo 10
Atlanta 10
Catania 10
Hanover 10
Messina 10
Moscow 10
Falls Church 9
Foggia 9
Indiana 9
Lanzhou 9
Phoenix 9
Norwalk 8
Central 7
Changchun 7
Favara 7
Cagliari 6
Den Haag 6
Durham 6
Edinburgh 6
Hefei 6
Ludhiana 6
Marsala 6
Montréal 6
Orange 6
Pune 6
Torino 6
Venice 6
Council Bluffs 5
Totale 12.235
Nome #
1,2,3-Triazole in Heterocyclic Compounds, Endowed with Biological Activity, through 1,3-Dipolar Cycloadditions 353
null 241
1,2-Dihydropyrazole[1,2-a]benzo[1,2,4]triazine-3-one: deaza analogue tricyclic scaffold with valuable antiproliferative activity 210
1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, Synthesis, and Biological Activity of New Antitumor Agents 202
1,3-Dipolar cycloaddition in the synthesis of a new potential DNA-intercalating agent: indolo[3,2-e]pyrrolo[1,2-c]triazolo[1,5-a]pyrimidine 191
Annelated Pyrrolo-pyrimidines from Amino-cyanopyrroles and BMMAs as Leads for New DNA-interactive Ring Systems 184
1,3-Dipolar cycloadditions in the synthesis of annelated diazines: design of new scaffolds for anticancer and antimicrobial agents 182
In vitro and in silico studies of polycondensed diazine systems as anti-parasitic agents 175
Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and molecular modelling studies 167
Pyrazolo[3,4-d][1,2,3]triazolo[1,5-a]pyrimidine: a new ring system through Dimroth rearrangement 166
Lead optimization through VLAK protocol: New annelated pyrrolo-pyrimidine derivatives as antitumor agents 163
Hsp60, a novel target for antitumor therapy: Structure-function features and prospective drugs design 160
Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation 159
3D-QSAR Pharmacophore Modeling and in Silico Screening of new Bcl-xl Inhibitors 159
Theoretical Determination of the pK a Values of Betalamic Acid Related to the Free Radical Scavenger Capacity: Comparison Between Empirical and Quantum Chemical Methods 158
Inside the Hsp90 inhibitors binding mode through induced fit docking 157
Predicting Skin Permeability by Means of Computational Approaches: Reliability and Caveats in Pharmaceutical Studies 155
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri 153
A Multivariate Analysis of HIV-1 Protease Inhibitors and Resistance Induced by Mutation 150
Docking and synthesis of pyrrolopyrimidodiazepinone derivatives (PPDs) and their precursors: new scaffolds for DNA-interacting agents 149
DNA minor groove binders: an overview on molecular modeling and QSAR approaches 147
Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors 147
Molecular Dynamics studies on Mdm2 complexes: an analysis of the inhibitor influence 146
Bis-1,2,4-triazolo[4,3-a:3',4'-c]quinoxalines of pharmaceutical interest from 1,3-dipolar cycloaddition 145
Reactivity of asymmetric benzo-condensed diazines with nitrilimine dipoles in the 1,3-dipolar cycloaddition reactions 145
G-quadruplex vs. duplex-DNA binding of nickel(II) and zinc(II) Schiff base complexes 145
A multivariate analysis on non-nucleoside HIV-1 reverse transcriptase inhibitors and resistance induced by mutation 144
Molecular dynamics studies on HIV-1 protease: a comparison of the flap motions between wild type protease and the M46I/G51D double mutant 141
Synthesis and biological activities of a new class of heat shock protein 90 inhibitors, designed by energy-based pharmacophore virtual screening 141
ISOINDOLO[2,1-C]BENZO[1,2,4]TRIAZINES: A NEW RING SYSTEM WITH ANTIPROLIFERATIVE ACTIVITY 140
Combined use of PCA and QSAR/QSPR to predict the drugs mechanism of action. An application to the NCI ACAM Database 139
In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators 138
A3 adenosine receptor: Homology modeling and 3D-QSAR studies 137
Pirazolo[3,4-d][1,2,3]triazolo[1,5-a]pirimidina: accesso sintetico tramite cicloaddizioni 1,3-dipolari e riarrangiamento di Dimroth 135
Docking of indolo- and pyrrolo-pyrimidines to DNA. New DNA-interactive polycycles from amino-indoles/pyrroles and BMMA. 135
Indicaxanthin from Opuntia ficus-indica Crosses the Blood−Brain Barrier and Modulates Neuronal Bioelectric Activity in Rat Hippocampus at Dietary-Consistent Amounts. 135
The interaction of Schiff Base complexes of nickel(II) and zinc(II) with duplex and G-quadruplex DNA 135
Exploring the anticancer potential of pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-one derivatives: The effect on apoptosis induction, cell cycle and proliferation 135
Design and Synthesis of 4-Substituted Indolo[3,2-e][1,2,3]triazolo[1,5-a]pyrimidine Derivatives with Antitumor Activity 134
An Unexpected Dimroth Rearrangement Leading to Annelated Thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with Potent Antitumor Activity 134
Study of the role of “gatekeeper” mutations V654A and T670I of c-kit kinase in the interaction with inhibitors by means mixed molecular dynamics/docking approach 131
A multivariate analysis on HIV-1 protease inhibitors and resistance induced by mutation 129
Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors 129
DOCKING AND MULTIVARIATE METHODS TO EXPLORE HIV-1 DRUG-RESISTANCE: A COMPARATIVE ANALYSIS 129
Synthesis and Antiproliferative Activity of [1,2,3,5]tetrazino[5,4-a]indoles, a New Class of Azolo-tetrazinones 128
Molecular Docking approach on the Topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database 128
Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations 128
Principal component analysis on molecular descriptors as an alternative point of view in the search of new Hsp90 inhibitors 127
Does ligand symmetry play a role in the stabilization of DNA g-quadruplex host-guest complexes? 127
Study of Reactivity in the 1,3-Dipolar Cycloaddition Reactions Leading to New Triazolopyrrolopyrazine Ring Systems 125
Nickel(II), copper(II) and zinc(II) metallo-intercalators: structural details of the DNA-binding by a combined experimental and computational investigation 124
MADoSPRO: a new Approach to Molecular Modelling Studies on a Series of DNA Minor Groove Binders 122
A QSAR study investigating the potential anti-HIV-1 effect of some Acyclovir and Ganciclovir analogs 122
New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol 122
DNA-binding of nickel(II), copper(II) and zinc(II) complexes: structure-affinity relationships 121
Synthesis, antiproliferative activity, and in silico insights of new 3-benzoylamino-benzo[ b ]thiophene derivatives 119
Micelles of the chiral biocompatible surfactant (1R,2S)-dodecyl-(2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium bromide (DMEB): Molecular dynamics and fragmentation patterns in the gas phase 119
Sintesi di Nuovi Derivati del Sistema Triciclico Pirazolo[3,4-d][1,2,3]triazolo[1,5-a]pirimidinico DNA interattivi 118
Antiproliferative activity of Pyrrolo[3,2-c]quinoline derivatives 117
A human CCT5 gene mutation causing distal neuropathy impairs hexadecamer assembly in an archaeal model 117
Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach 117
Design, synthesis, and biological evaluation of pyridothienotriazolopyrimidine derivatives as new HSP90 inhibitors 112
New benzothieno[3,2-d]-1,2,3-triazines with antiproliferative activity: Synthesis, spectroscopic studies, and biological activity 111
Recent advances on CDK inhibitors: An insight by means of in silico methods 111
PROGETTAZIONE, SINTESI E VALUTAZIONE BIOLOGICA DI NUOVI INIBITORI DI HSP90 109
Micelles, Rods, Liposomes, and Other Supramolecular Surfactant Aggregates: Computational Approaches 109
A convenient synthesis of cycloadduct bis-1,2,4-triazolo[4,3-a:3’,4’-c]quinoxalines by 1,3-dipolar cycloaddition 108
Design, synthesis and preliminary evaluation of dopamine-amino acid conjugates as potential D1 dopaminergic modulators 108
Sintesi di Oligopeptidi Pirrolici Isomeri della Distamicina e della Netropsina 106
Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target 106
Benzothieno-triazolo-pyrimidine: a new class of potential DNA-binders 105
Intercalation of daunomycin into stacked DNA base pairs. DFT study of an anticancer drug 105
A synthetic approach to new polycyclic ring system of biologial interest through domino reaction: indolo[2,3-e][1,2,3]triazolo[1,5-a]pyrimidine 104
In silico, spectroscopic, and biological insights on annelated pyrrolo[3,2-e]pyrimidines with antiproliferative activity 104
A3 Adenosine Receptor: homology modeling and 3D-QSAR studies 103
IKK-beta inhibitors: An analysis of drug–receptor interaction by using Molecular Docking and Pharmacophore 3D-QSAR approaches 102
Design of new DNA-interactive agents by molecular docking and QSPR approach 99
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach 99
Reattività di diazine benzocondensate asimmetriche nelle reazioni di cicloaddizione 1,3-dipolare con dipoli nitriliminici 97
Bis-1,2,4-triazolo[4,3-a:3’,4’-c]quinoxalines of pharmaceutical interest from 1,3-dipolar cycloaddition 97
Principal Component Analysis on molecular descriptors as alternative point of view in the search of new Hsp90 inhibitors 97
Pharmacophore modelling as useful tool in the lead compounds identification and optimization 95
A new Approach to Molecular Modelling Studies on a Series of DNA Minor Groove Binders 94
SYNTHESIS AND PHOTOCHEMIOTHERAPEUTIC ACTIVITY OF THIOPYRANO[2,3-E]INDOL-2-ONES 94
A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α 94
Molecular Modeling Approaches in the Discovery of New Drugs for Anti-Cancer Therapy: The Investigation of p53-MDM2 Interaction and its Inhibition by Small Molecules 93
LOOKING FOR NEW HSP-90 INHIBITORS THROUGH A MOLECULAR DOCKING/PHARMACOPHORE APPROACH 92
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs) 92
Zinc complexes as fluorescent chemosensors for nucleic acids: New perspectives for a "boring" element 90
2,5-bis(3'-Indolyl)thiophenes, Analogues of Marine Alkaloid Nortopsentin. 89
Nuovi inibitori di Aurora chinasi A come target biologico coinvolto nei processi carcinogenici 88
20Th International Congress of Heterocyclic Chemistry (20ICHC) 87
Sintesi ed Attivita’ Fotobiologica di Tiopirano[2,3-c]indol-2-oni 87
Virtual lock-and-key approach: The in silico revival of Fischer model by means of molecular descriptors 87
2-OXO-[1,4]OXAZINO[3,2-E]INDOLE: A NEW RING SYSTEM WITH POTENTIAL PHOTOBIOLOGICAL PROPERTIES 86
Sintesi di derivati tetraidrobis-triazolochinossalinici e di nuovi sistemi triazolopirrolopirazinici di interesse biologico mediante cicloaddizioni 1,3-dipolari 84
Bcl-2 come target di farmaci antitumorali modulatori dell'apoptosi 84
Selective G-Quadruplex Stabilizers: Schiff-base Metal Complexes with Anticancer Activity 83
Multivariate analysis in the identification of biological targets for designed molecular structures: The BIOTA protocol 82
The Interaction of Small Molecules with Biomolecules 81
Totale 12.805
Categoria #
all - tutte 58.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019896 0 0 0 0 0 0 0 0 0 190 357 349
2019/20204.594 536 173 271 327 491 662 500 272 441 228 486 207
2020/20212.889 97 282 92 303 298 127 237 205 359 359 212 318
2021/20222.522 226 522 50 102 39 90 120 107 286 313 144 523
2022/20232.761 358 381 64 264 362 442 148 204 304 49 123 62
2023/20241.279 108 205 96 126 127 283 202 55 37 40 0 0
Totale 18.938